Digital Biology & Genetics

Global Alliance for Genomics and Health picks 7 data initiatives for 2019

The Global Alliance for Genomics and Health has chosen seven genomic data initiatives from around the world as new Driver Projects for 2019 projects where researches will work together develop and pilo standards for the sharing genomic and other health data.Those projects are:Human Heredity and Health in AfricaGEnome Medical alliance JapanEuropean Joint Programme on Rare

[ Read More ]

Why You Should Be Careful About 23andMes Health Test

Last month, the DNA-testing company 23andMe secured Food and Drug Administration approval for a new screening for gene-based health risks. Along with celiac disease, Alzheimers, Parkinsons, breast cancer and several other medical conditions, the company can now screen clients for two mutations that have been linked to colorectal cancer.But F.D.A.-approved does not necessarily mean clinically

[ Read More ]

Artificial intelligence applied to the genome identifies an unknown human ancestor

By combining deep learning algorithms and statistical methods, investigators from the Institute of Evolutionary Biology (IBE), the Centro Nacional de Anlisis Genmico (CNAG-CRG) of the Centre for Genomic Regulation (CRG) and the Institute of Genomics at the University of Tartu have identified, in the genome of Asian individuals, the footprint of a new hominid who

[ Read More ]

Pharmacogenomics: The Science of Personalizing Drugs Based On DNA

We strongly believe that only digital health can bring healthcare into the 21st century and make patients the point-of-care. Individuals share about 99.97 percent of their DNA and only the remaining 0.03 percent is responsible for the differences in skin, hair or eye color, height, shoe size or sunspots. Scientists discovered somewhat recently that our

[ Read More ]

How Sean Parker is working to build a clone army of cancer-killing assassins for patients

In healthcare, you can’t be a specialist in everything.When Silicon Valley veteran and billionaire philanthropist Sean Parker learned this lesson, he homed in quickly on what we wanted to focus on at his $250 million immunotherapy institute: turning cells into a clone army of cancer-killing assassins, Parker said. It’s a focus that could once again

[ Read More ]